Method of preparing and using isoflavones for the treatment of neurological symptoms
Abstract
A composition is prepared by extracting phytochemicals from plant matter and is administered to provide treatment for mental conditions and nerve problems, especially neurological symptoms, immunological symptoms, migraine headaches, inflammations and dementia. This composition is enriched preferably with two or more fractions of plant matter, namely: isoflavones, lignans, saponins, sapogenins, catechins and phenolic acids. The isoflavones are taken from a group including malonyl, acetyl, glucoside and aglycone. Soy is the preferred source of these chemicals; however, other plants may also be used, such as wheat, psyllium, rice, oats, red clover, kudzu, alfalfa, flax, and cocoa. The composition is a dietary supplement for treatment of various syndromes and disorders presented in a concentrated, easily delivered and consumed dosage, such as a health bar.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A composition for treatment of conditions involving neurological symptoms, immunological symptoms, inflammation, migraine headaches and dementia, said composition being made from a plant matter in which the composition is a medicament enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids, wherein said isoflavone is selected from a group consisting of malonyl, acetyl, glucoside, and aglycone, said medicament having an effective amount of phytochemicals selected on a basis of a therapeutic treatment for neurological symptoms, immunological symptoms, inflammation, migraine headache and dementia.
2. The composition of claim 1 in which the ratio of isoflavones to saponins is selected from the range of about 1:10 to about 10:1.
3. The composition of claim 1 in which the isoflavones are present in an amount form approximately 5% to approximately 90% by weight.
4. The composition of claim 1 in which the lignans are present in an amount from about 1% to about 70% by weight.
5. The composition of claim 1 in which said medicament is in a form of a product for oral delivery, said product form being selected from a group consisting of a concentrate, liquid, dried powder, capsule, pellet, pill, and a food supplement including a food bar in a concentrated form with an easy to consume dosage.
6. The composition of claim 1 wherein said therapeutic amount of said medicament is selected on a basis of a treatment for neurology.
7. The composition of claim 1 wherein said therapeutic amount of said medicament is selected on a basis of a treatment for immunology.
8. The composition of claim 1 wherein said therapeutic amount of said medicament is selected on a basis of a treatment for migraine headache.
9. The composition of claim 1 wherein said therapeutic amount of said medicament is selected on a basis of a treatment for dementia.
10. The composition of claim 1 wherein said phytochemicals are concentrated at least approximately 100 times more than said phytochemicals are concentrated in the original plant matter from which said phytochemicals are extracted.
11. The composition of claim 1 wherein said isoflavone is a food in a concentrated, easy to deliver and consume dosage.Join the waitlist — get patent alerts
Track US6391310B1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.